title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"DLocal, Allogene Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - DLocal  ( NASDAQ:DLO ) ",20240515T101221,https://www.benzinga.com/news/24/05/38837718/dlocal-allogene-therapeutics-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session,ALLO,0.334762,Neutral,0.129047
Allogene  ( ALLO )  Down 20% on Strategic Changes in Pipeline,20240105T175200,https://www.zacks.com/stock/news/2206512/allogene-allo-down-20-on-strategic-changes-in-pipeline,ALLO,0.354319,Neutral,0.076714
Stocks That Hit 52-Week Lows On Friday,20220422T162629,https://www.benzinga.com/markets/options/22/04/26764450/52-weeks-high-and-low-article,ALLO,0.012589,Neutral,0.003576
"Poseida Therapeutics, Inc.  ( PSTX )  Reports Q2 Loss, Tops Revenue Estimates",20240805T215508,https://www.zacks.com/stock/news/2316456/poseida-therapeutics-inc-pstx-reports-q2-loss-tops-revenue-estimates,ALLO,0.205225,Neutral,0.0
"CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies - Cartesian, Arcellx, Novartis, Bristol-Myers Squibb, CARsgen, Poseida, Juno, CRISPR, bluebird bio",20230925T210100,https://www.prnewswire.com/news-releases/car-t-cell-therapy-for-multiple-myeloma-market-to-observe-stunning-growth-by-2032-evaluates-delveinsight--key-companies---cartesian-arcellx-novartis-bristol-myers-squibb-carsgen-poseida-juno-crispr-bluebird-bio-301937157.html,ALLO,0.05623,Neutral,0.045942
